Cleared Traditional

Neurovascular Access System Family (K240746) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K240746 · Q'Apel Medical, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2024
Decision
246d
Days
Class 2
Risk

K240746 is an FDA 510(k) clearance for the Neurovascular Access System Family. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Q'Apel Medical, Inc. (Fremont, US). The FDA issued a Cleared decision on November 20, 2024 after a review of 246 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Q'Apel Medical, Inc. devices

Submission Details

510(k) Number K240746 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 2024
Decision Date November 20, 2024
Days to Decision 246 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d slower than avg
Panel avg: 148d · This submission: 246d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Insight Medical, LLC
Wanda Carpinella

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K240746.
Access25™ Delivery Microcatheter
K242033 · Penumbra, Inc. · Dec 2024
87 NeuGlide Catheter
K240971 · Piraeus Medical · Dec 2024
Socrates 38 Catheter
K242301 · Scientia Vascular, Inc. · Dec 2024
Zipline Access Catheter
K240711 · Perfuze, Ltd. · Oct 2024
CEREGLIDE 42 Intermediate Catheter
K241244 · Cerenovus, Inc. · Oct 2024
8F Modified Sheath System
K240529 · Route 92 Medical, Inc. · Oct 2024